Evaluation of the safety and efficacy of a monoclonal antibody to treat Influenza

Trial Identifier:	D6000C00004
Sponsor:	MedImmune, LLC
NCTID::	NCT03903718
Start Date:	April 2020
Primary Completion Date:	October 2020
Study Completion Date:	October 2020
Condition:	Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, CA	Cypress, CA, United States of America, 90630

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.